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Multidrug resistance (MDR) in animal and human cell lines
is often associated with a reduction in cellular accumulation
of the drugs concerned (Kessel et al., 1968; Dano, 1973).
Drug transport studies have shown that this is a facet of
altered translocation of drugs across the plasma membrane
which may involve both decreased drug penetration and/or
increased drug efflux (Skovsgaard, 1978; Inaba et al., 1981).
Many studies have therefore focussed on the composition of
this organelle in order to identify the molecular basis of drug
resistance (for review see Riordan & Ling, 1985). By far the
most striking membrane alteration in several MDR cells is
the presence of a high molecular weight glycoprotein family
(P-glycoprotein) (Juliano & Ling, 1976; Biedler & Peterson,
1981; Kartner et al., 1983). In addition to P-glycoprotein
hyperexpression, a small acidic cytosolic protein called V19
(Meyers & Biedler, 1981), CP22 (Koch et al., 1986) or Sorcin
(Van der Bliek et al., 1986), has also been noted in some
hamster and mouse MDR cell lines. Although the role of
this protein is uknown, it is able to bind calcium with high
affinity (Koch et al., 1986) suggesting that altered calcium
metabolism may also be a component of the MDR
phenotype. The present study indicates that in addition to
hyperexpression of V19/CP22/Sorcin and P-glycoprotein,
structural changes in the endoplasmic reticulum (ER) also
occur in MDR CHRCS cells.
The adenosine-, thymidine- and glycine-requiring
auxotroph AUXBI of CHO cells and its colchicine-resistant
mutant CHRCS were obtained from Dr Ling of the Ontario
Cancer Institute, Toronto, Canada. Cells were grown in
suspension in cx-Minimal Essential Medium containing 10%
foetal calf serum, streptomycin and penicillin. Membrane
isolation was either by use of a Stansted cell disruptor,
exactly as described by Riordan and Ling (1979), or by
ultrasonic disintegration for 5 sec at 4°C using a MSE
sonicator, model 1276, amplitude setting 22 microns. After
disruption or sonication the following differential
centrifugation steps were applied: nuclear spin, 300g for
10min at 4"C; mitochondrial spin, 4000g for 10min at 4 C;
microsomal spin, 35,000g for 30min at 4°C. The resulting
microsomal pellet was either dissolved in 0.1% SDS prior to
protein determination and gel electrophoresis or was applied
to a discontinuous sucrose gradient consisting of 60% (w/v),
45%, 31% and 16% sucrose, and centrifuged at 76900g for
18 h according to Riordan and Ling (1979). Material
banding at the three interfaces was collected, washed and
solubilised in 0.1% SDS. Aliquots of whole cell homogenate
were also solubilised in 0.1% SDS. Protein determinations
were according to Lowry et al. (1951).
SDS-polyacrylamide gel electrophoresis was carried out
according to Laemmli (1970) and employed a 10% SDS gel
run under reducing conditions. Gels were stained with
PAGE blue 83 (BDH Chemicals Ltd, Poole, UK). Transfer
of resolved proteins from SDS gels to nitrocellulose filter
paper was essentially as described by Towbin (1979). Protein
transfer was performed for 4h at 4°C at a constant current
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of 0.5A using a solution containing 0.0125M Tris-base, 0.2M
glycine (pH 8.5) and 20% methanol as electrode buffer. Prior
to immunoblotting additional protein binding sites on the
nitrocellulose filter paper were blocked by incubation in
5mM EDTA, 0.25% gelatin, 0.01 M NaN3, 0.15M NaCl,
0.05M Tris base and 0.05% NP40. The nitrocellulose paper
was then incubated overnight with monospecific affinity
purified antibody to endoplasmin (Koch et al., 1987). After
washing 1251 protein A autoradiography was used to
visualise antibody binding to protein bands.
The method for the detection of calcium binding proteins
by 45Ca autoradiography on nitrocellulose paper was
according to Maruyama et al. (1984). After transfer of
cytosolic proteins, the paper was soaked in a solution
containing 60mM KCI, 5mM MgCl2 and 10mM Tris-HCl
(pH6.8) prior to incubation in the same buffer containing
0.5 mCi 1- 1 45Ca Cl2 (Amersham International, Aylesbury,
UK) for 10min. The nitrocellulose paper was rinsed in
distilled water for 5min, dried and autoradiographed.
Analysis of microsomal membrane proteins from CHRCS
and AUXBI cells by SDS gel electrophoresis revealed
increased levels of a protein having a relative molecular mass
of 92kDa in the drug resistant line (Figure 1). This increase
was observed in microsomal membranes prepared either by
sonication or by use of a Stansted cell disruptor. Conversely,
levels of the 92kDa protein were consistently greater in the
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Figure 1 SDS gel electrophoresis of microsomal membrane
proteins from AUXBI cells (track 2) and CHRCS cells (track 3)
showing increased levels of 92kDa protein in the drug resistant
line. Molecular weight markers (track 1): phosphorylase B
92.5 kDa, bovine serum albumin 66.2kDa, ovalbumin 45 kDa,
carbonic anhydrase 31 kDa, soybean trypsin inhibitor 21.5kDa.
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Figure 2 Western blot analysis of endoplasmin content in whole cell homogenates and subcellular fractions from AUXBI and
CHRC5 cells. lOO1pg protein were analysed by SDS-gel electrophoresis and immunoblotting with antibody to endoplasmin (top half
of blot). The 92kDa band (indicated by the arrow) is the major immunopositive band. Tracks 1 and 2 AUXBI and CHRC5
respectively, whole cell homogenates prepared by Stansted cell disruption; Tracks 3 and 4 AUXBI and CHRC5 respectively, whole
cell homogenates prepared by sonication; Tracks 5 and 6 AUXBI and CHRC5 respectively, whole cell homogenates prepared by
Stansted cell disruption; Tracks 7 and 8 AUXBI and CHRC5 respectively, microsomal membranes prepared by Stansted cell
disruption, Tracks 9 and 10 AUXBI and CHRC5 respectively, cytosol extracts prepared by Stansted cell disruption. The lower half
of the blot has been reacted with affinity purified antibody to the cytosolic, drug resistance associated protein CP22.
soluble fraction (cytosol) from AUXBI cells than in that
from CHRC' cells. Gel electrophoresis of microsomal
membranes banding at the 31-45 and 45-60 sucrose density
interfaces similarly revealed increased levels of the 92kDa
protein in the drug resistant cell line suggesting that the
observed change in the level of the 92kDa protein in the
microsomal membranes of resistant CHO cells following
disruption does not result from differences in the purity of
microsomal material produced by sonication or by
mechanical disruption. Gel electrophoresis failed to show the
presence of this protein in plasma membrane-derived
material banding at the 16-31 sucrose density interface.
Analysis of whole cell homogenates by gel electrophoresis
showed no difference in the overall expression of the protein
in CHRC' cells and AUXBI cells.
Figure 2 shows that the major protein band recognised by
the monospecific affinity-purified anti-endoplasmin antibody
was the 92kDa protein. Densitometry was used to confirm
that following disruption, significantly more of this protein is
associated with the microsomal membranes from CHRCS
cells than with those from AUXBI cells, that there is much
less of this protein in the microsomal supernatant from
CHRCS cells than from AUXBI cells, and that the total
amounts of this protein in whole cell homogenates is no
different in the two cell types.
When microsomal membranes from CHRCS cells were
probed for Ca2 + binding proteins after SDS gel
electrophoresis and electroblotting, the 92kDa protein was
the only protein capable of binding Ca2 + in the micromolar
range (Figure 3).
It is highly likely that the 92kDa protein described in this
study is the major glycoprotein, endoplasmin (Koch et al.,
1987), based on its reactivity with an affinity purified
antibody to endoplasmin and on its ability to bind Ca2 .
Endoplasmin has been shown to be localised to the
endoplasmic reticulum and is the same as one of the major
stress related proteins GRP94 (Koch et al., 1987).
Immunoblotting analyses show that overall expression of
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Figure 3 Binding of Ca2 + to 92 kDa protein in microsomal
membranes (track I) and the cytosol fraction (track 2) from
CHRC5 cells. The affinity of the 92kDa protein for calcium is
comparable to that of the calcium binding protein, CP22.
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endoplasmin is no different in drug sensitive or resistant
CHO cells and that the higher levels observed in CHRC5
microsomal membranes result from increased retention of
the glycoprotein in the microsomal fraction during
subcellular fractionation. Since endoplasmin is a luminal
protein of the ER (Koch et al., in preparation), these
observations indicate that structural changes occur in the ER
of drug resistant cells which alter the orientation of
vesiculation upon disruption, and thereby cause release of
ER proteins into the soluble phase. This in turn implies that
membrane changes associated with the resistant phenotype
are not confined to the plasma membrane. Such changes
could be the result of a general alteration in the composition
of membranes in resistant cells as suggested by studies
showing changes in membrane lipid composition upon
development of the drug resistance phenotype (Rintoul &
Center, 1984; Riordan & Ling, 1985). However, it is also
noteworthy that the ER is a major calcium store in cells
(Streb et al., 1983) and that calcium metabolism appears to
be an important, albeit ill-defined, component of the drug
resistance mechanism in drug resistant cells (Tsuruo et al.,
1982; Koch et al., 1986; Nair et al., 1986). Thus the
alterations in the ER described in this study may be more
directly implicated in the maintenance of the drug resistant
phenotype.
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